To innovate for FIC & BIC drugs is the core and spirit of our R&D strategy, while we maintain a healthy balance between potential value and risk control.
We closely track relevant novel technologies and scientific discoveries, with an unchanging aim of addressing global unmet medical needs.
We focus on adopting new technology of the “Slope of Enlightenment” and early “Plateau of Productivity” stage to build into our product pipeline and technology platform. At the same time, we encourage our discovery team to explore earlier stage technology.
